Legal Disclaimer
This page provides general legal orientation for Spain, not legal advice. Regulations change frequently. Always verify current rules with AEMPS and consult a qualified professional.
Peptide Legal Status in Spain
Spain regulates medicines through AEMPS under the Ley de Garantías y Uso Racional de los Medicamentos. GLP-1 agonists are EMA-authorized and available by prescription. Spain experienced significant Ozempic shortages due to off-label prescribing for weight loss, leading to enhanced prescription monitoring. Telehealth prescribing is permitted within established frameworks.
Regulator
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) — Official website
Key Facts
Compounding Pharmacy Rules
Telehealth Prescribing
Peptide Categories in Spain
Approved
Semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Saxenda) — EMA-authorized, prescription-only. Financiación pública (SNS) covers diabetes indications; weight loss typically private pay.
Research / Unapproved
BPC-157, GHRPs — no AEMPS authorization. Sale of unauthorized medicines is prohibited under Spanish law. AEMPS monitors and may take action against unauthorized products.
Banned / Restricted
Medicamentos sin autorización. AEMPS maintains a system of pharmacovigilance (Sistema Español de Farmacovigilancia).
Key Legislation
- Ley 29/2006 de Garantías y Uso Racional de los Medicamentos
- Real Decreto Legislativo 1/2015 (texto refundido)
- Real Decreto 81/2014 (receta médica y prescripción electrónica)
Peptides in Spain: FAQ
Sources
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.
Peptide Laws in Other Countries
Get international legal updates
Stay informed when country-specific legal pages, routing guidance, and safety guidance change.
No spam. Unsubscribe anytime.